Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-20-000022
Filing Date
2020-07-31
Accepted
2020-07-30 21:58:33
Documents
86
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20200630.htm   iXBRL 10-Q 2080944
2 EX-31.1 ex06302020311.htm EX-31.1 16400
3 EX-31.2 ex06302020312.htm EX-31.2 16061
4 EX-32.1 ex06302020321.htm EX-32.1 12448
5 EX-32.2 ex03312020322.htm EX-32.2 12519
11 rtrx-20200630_g1.jpg GRAPHIC 62684
  Complete submission text file 0001438533-20-000022.txt   8615942

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20200630.xsd EX-101.SCH 47158
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20200630_cal.xml EX-101.CAL 102925
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20200630_def.xml EX-101.DEF 233902
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20200630_lab.xml EX-101.LAB 582713
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20200630_pre.xml EX-101.PRE 398899
12 EXTRACTED XBRL INSTANCE DOCUMENT rtrx-20200630_htm.xml XML 1584739
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 201063502
SIC: 2834 Pharmaceutical Preparations